Key facts
- This page summarizes Howard Berman's Form 3 filing for Atea Pharmaceuticals, Inc. (AVIR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Jun 2025, 18:00.
Howard Berman - 20 Jun 2025 Form 3 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)
- Reporting relationship
- Director
- Issuer ticker
- AVIR
- Reported as of
- 20 Jun 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 24 Jun 2025, 18:00:05 UTC
- Prior SEC filing
- 13 Jan 2025
- Next SEC filing
- 26 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrea Corcoran, as Attorney-in-Fact for Howard Berman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Howard Berman filed Form 3 for Atea Pharmaceuticals, Inc. (AVIR) on 24 Jun 2025.
Change
- Previous filing in this sequence was filed on 13 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001952986
Primary reporting owner
Berman Howard
- Relationship
- Director
- Address
- 225 FRANKLIN STREET SUITE 2100, BOSTON
- Signature
- /s/ Andrea Corcoran, as Attorney-in-Fact for Howard Berman
- Signature date
- 24 Jun 2025
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Exhibit List - Exhibit 24 - Section 16 and Form 144 Power of Attorney